PharmRep Direct from the editors of Pharmaceutical Representative Visit www.PharmRep.com Today!

March 25, 2011 Issue 56 Vol. 2
www.pharmrep.com  
Contact Editor: Reid Paul
PharmRep Direct News

Promising Drugs in Europe Hit US Snag
AstraZeneca’s Brilinta and Pharming’s Ruconest, named by a Thomson Reuters report as two of the most promising drugs to watch this year, have been held up during FDA’s review process.
» MORE

Making Sense of Market Chaos
Pharma’s vision usually consists of a threefold commitment: to advance new science, serve the patient, and wrest reimbursement access from an even more myopic class of payers and providers. But is this enough?
»
MORE

FDA Files Consent Decree against Johnson & Johnson
The action prevents McNeil from manufacturing and distributing drugs from its Fort Washington, Pennsylvania, facility until FDA determines that its operations comply with the law
» MORE

PharmRep Direct Features

Burden of Proof
Building credibility with physicians requires trust, knowledge and enough evidence to make a powerful point.
» MORE

From Market to Market
Not all territories are alike, okay? The faster companies develop regional approaches to sales, the quicker they’ll be able to react to changing conditions.
» MORE

Growing Stronger After the Storm
To manage through a resource-constrained environment, it is essential to get the most out of procurement planning.
» MORE

 
FindPharma   Search
 
Subscribe To PharmRep Today!
PharmRep Direct Quick Links
Health insurance CEOs reap big pay days

Behind the Pfizer curtain

Pharma CEO pay packages

Follow Pharm Rep on Twitter

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA
.

Visit PharmRep.com Today! Visit www.PharmRep.com Today!